|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
77,921,000 |
Market
Cap: |
N/A |
Last
Volume: |
4,773,204 |
Avg
Vol: |
2,175,956 |
52
Week Range: |
$81.49 - $81.49 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
S&P 400 MIDCAP |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Savini Carl A |
EVP, Chief Admin. Off |
|
2009-12-21 |
4 |
D |
$59.75 |
$91,537 |
D/D |
(1,532) |
62,932 |
|
- |
|
Russell Lesley |
Exec. V.P., Chief Medical Off |
|
2009-12-21 |
4 |
D |
$59.75 |
$69,131 |
D/D |
(1,157) |
53,499 |
|
- |
|
Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
|
2009-12-21 |
4 |
D |
$59.75 |
$89,864 |
D/D |
(1,504) |
50,582 |
|
- |
|
Buchi J Kevin |
Exec. V.P., CFO |
|
2009-12-21 |
4 |
D |
$59.75 |
$74,150 |
D/D |
(1,241) |
85,239 |
|
- |
|
Baldino Frank Jr |
Chairman and CEO |
|
2009-12-21 |
4 |
D |
$59.75 |
$478,956 |
D/D |
(8,016) |
546,582 |
|
- |
|
Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
|
2009-12-21 |
4 |
D |
$59.75 |
$90,940 |
D/D |
(1,522) |
72,939 |
|
- |
|
Baldino Frank Jr |
Chairman and CEO |
|
2009-12-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
431 |
543,942 |
|
- |
|
Baldino Frank Jr |
Chairman and CEO |
|
2009-12-17 |
4 |
GD |
$0.00 |
$0 |
D/D |
1,279 |
544,373 |
|
- |
|
Baldino Frank Jr |
Chairman and CEO |
|
2009-12-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
428 |
545,652 |
|
- |
|
Baldino Frank Jr |
Chairman and CEO |
|
2009-12-14 |
4 |
D |
$59.13 |
$474,341 |
D/D |
(8,022) |
554,598 |
|
- |
|
Baldassano Valli F. |
Exec. VP, Chief Compliance Off |
|
2009-12-14 |
4 |
D |
$59.13 |
$16,970 |
D/D |
(287) |
31,379 |
|
- |
|
Vaught Jeffry L |
Exec. V.P., Chief Scientific |
|
2009-12-14 |
4 |
D |
$59.13 |
$88,872 |
D/D |
(1,503) |
67,933 |
|
- |
|
Savini Carl A |
EVP, Chief Admin. Off |
|
2009-12-14 |
4 |
D |
$59.13 |
$90,587 |
D/D |
(1,532) |
64,464 |
|
- |
|
Russell Lesley |
Exec. V.P., Chief Medical Off |
|
2009-12-14 |
4 |
D |
$59.13 |
$68,413 |
D/D |
(1,157) |
54,656 |
|
- |
|
Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
|
2009-12-14 |
4 |
D |
$59.13 |
$88,872 |
D/D |
(1,503) |
52,086 |
|
- |
|
Buchi J Kevin |
Exec. V.P., CFO |
|
2009-12-14 |
4 |
D |
$59.13 |
$73,380 |
D/D |
(1,241) |
86,480 |
|
- |
|
Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
|
2009-12-14 |
4 |
D |
$59.13 |
$89,996 |
D/D |
(1,522) |
74,461 |
|
- |
|
Vaught Jeffry L |
Exec. V.P., Chief Scientific |
|
2009-12-11 |
4 |
D |
$58.94 |
$88,587 |
D/D |
(1,503) |
69,436 |
|
- |
|
Roche Robert P Jr |
Exec. VP, WW Pharm Ops |
|
2009-12-11 |
4 |
D |
$58.94 |
$88,587 |
D/D |
(1,503) |
53,589 |
|
- |
|
Russell Lesley |
Exec. V.P., Chief Medical Off |
|
2009-12-11 |
4 |
D |
$58.94 |
$68,194 |
D/D |
(1,157) |
55,813 |
|
- |
|
Savini Carl A |
EVP, Chief Admin. Off |
|
2009-12-11 |
4 |
D |
$58.94 |
$90,296 |
D/D |
(1,532) |
65,996 |
|
- |
|
Pappert Gerald J. |
Exec. V.P., General Counsel |
|
2009-12-11 |
4 |
D |
$58.94 |
$69,844 |
D/D |
(1,185) |
28,815 |
|
- |
|
Buchi J Kevin |
Exec. V.P., CFO |
|
2009-12-11 |
4 |
D |
$58.94 |
$73,145 |
D/D |
(1,241) |
87,721 |
|
- |
|
Grebow Peter E |
Exec. V.P.,Worldwide Tech. Ops |
|
2009-12-11 |
4 |
D |
$58.94 |
$89,707 |
D/D |
(1,522) |
75,983 |
|
- |
|
Baldassano Valli F. |
Exec. VP, Chief Compliance Off |
|
2009-12-11 |
4 |
D |
$58.94 |
$67,604 |
D/D |
(1,147) |
31,666 |
|
- |
|
491 Records found
|
|
Page 4 of 20 |
|
|